ICON News
Most Popular ICON Story
Pfizer turns to CROs as it upends huge R&D operation
As Pfizer hatchets billions of dollars from its R&D budget it's turning to two CROs as preferred providers for outsourcing its clinical trial work. In separate releases Parexel and Icon both Read more...
Latest Headlines
- November 20, 2008
- November 14, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
